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Abstract: Our aim was to compare the effects of a non-alcoholic Cabernet-Sauvignon (CS),  Malbec (M),  Merlot blend (BW) red wine 
extracts, Ilex paraguariensis (Ip) or Ilex brasiliensis (Ib) aqueous extracts, Vaccinium meridionale Swartz (mortiño) fermented extract (FE), 
berry juice (BJ) and polyphenols-riched fractions of cocoa(PFC) against reperfusion injury. Isolated rat hearts were submitted to 20 min of 
global ischemia (GI) and 30 min of reperfusion (R). Other hearts were treated 10 min before GI and first 10 min of R with the extracts. CS, 
M, Ip, Ib and FE attenuated the myocardial dysfunction and oxidative damage whereas BW, BJ and PFC were ineffective. Paradoxically, 
PFC had the highest and BW similar scavenging activity than protective extracts. The beneficial actions were lost when nitric oxide 
synthase (NOS) was inhibited. These data indicate that ¨in vitro¨ antioxidant capacity of natural products is not primarily responsible for the 
cardioprotection being involved NO-dependent pathways... 
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Resumen: Nuestro objetivo fue comparar los efectos de extractos no alcohólicos de los vinos tinto Cabernet-Sauvignon (CS), Malbec (M) y 
Merlot (BW), de extractos acuosos de Ilex paraguariensis (Ip) e Ilex brasiliensis (Ib), de un extracto fermentado (FE) de Vaccinium 
meridionale Swartz (mortiño), del jugo del mortiño (BJ) y de fracciones enriquecidas en polifenoles de cacao (PFC) sobre las alteraciones 
miocárdicas producidas por isquemia-reperfusión. Para ello, corazones aislados de rata fueron sometidos a 20 min de isquemia global (GI) y 
30 min de reperfusión (R). Otros corazones fueron tratados 10 minutos antes de GI y durante los primeros 10 minutos de la R con los 
extractos. CS, M, Ip, Ib y FE atenuaron la disfunción contráctil postisquémica y el daño oxidativo mientras que BW, BJ y PFC fueron 
ineficaces. Paradójicamente, PFC mostró la más alta y BW similar actividad antioxidante que los extractos protectores. Las acciones 
beneficiosas fueron abolidas cuando la óxido nítrico sintasa (NOS) fue inhibida. Estos datos indican que la capacidad antioxidante ¨in vitro¨ 
de los productos naturales no es el principal responsable de la cardioprotección estando involucradas vías dependientes del NO. 
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INTRODUCTION 
Reactive oxygen species (ROS) are 
characteristically unstable and very reactive oxygen-
derived small molecules. In the cardiovascular 
system, ROS can be produced by several different 
cellular sources, including mitochondria, xanthine 
oxidases, lipoxygenases, cyclooxygenases, uncoupled 
nitric oxide synthase (NOS), peroxidases, and 
nicotinamide adenine dinucleotide phosphate 
(NADPH) oxidases, as well as other heme-containing 
proteins (Zhang et al., 2012). Superoxide dismutase 
(SOD), glutathione peroxidase (GPx), catalase- as 
enzymatic antioxidant- and reduced glutathione 
(GSH), ascorbic acid, and tocopherol, are involved in 
the ROS detoxification (Baines et al., 2005). When 
the endogenous antioxidant defences are not enough 
to counterbalance the abrupt ROS production the 
¨oxidative stress¨ takes place. This misbalance has 
been implicated in many pathophysiological 
conditions one of which is during ischemia and 
reperfusion.  
After a short episode of ischemia (< 20 min) 
a transient myocardial dysfunction takes place 
without histological signs of irreversible injury. This 
phenomenon was called ‘myocardial stunning’ 
(Braunwald, 1991).  In this situation the abrupt ROS 
production occurring early on reperfusion is one of 
the responsible factors. According to this theory it 
would be possible to limit oxidative damage and 
ameliorate myocardial disease progression by 
supplementing antioxidants. Prevention rather than 
treatment of heart disease can significantly improve 
patients’ quality of life and reduce health care costs.  
A significant reduction in coronary artery 
disease incidence has been linked the consumption of 
herbal flavonoids (Keli et al., 1996; Arts et al., 2001; 
Mann et al., 2007). This beneficial action is based on 
several clinical studies that positively correlate 
flavonoid intake to a reduced incidence of the 
disease. A meta-analysis of prospective cohort 
studies concluded that high flavonoid intake from 
fruits, vegetables, tea, and red wine is associated with 
a reduced risk of ischemic heart disease (Huxley & 
Neil, 2003; Li et al., 2010). This effect has been 
associated to the high antioxidant power of those 
compounds. Indeed, numerous experimental studies 
show that natural antioxidants present in herbal 
extracts such as Salvia miltiorrhiza, Dracocephalum 
moldavica L. and Scutellaria baicalensis exert a 
cardioprotective effect against ischemia-reperfusion 
injury (Wang et al., 2011; Ge et al., 2014; Jiang et 
al., 2014). In this sense, experiments performed in 
our laboratory show the efficacy of a non-alcoholic 
extract of red wine (Mosca & Cingolani, 2000; 
Mosca & Cingolani, 2002), aqueous extracts of Ilex 
paraguariensis, Ilex brasiliensis (Schinella et al., 
2009), and Vaccinium meridionale Swartz (Lopera et 
al., 2013) in a model of a short period of ischemia 
inducing myocardial stunning. Unfortunately, most of 
the clinical trials carried out to test the ¨in vivo¨ 
efficacy of antioxidants could not measure any 
benefit of their administration (Levraut et al., 2003; 
Halliwell, 2011). Thus, recent studies indicate that 
the radical scavenger property is unlikely to be the 
only reason for their cardioprotective actions and in 
fact, a wide spectrum of cellular signalling events 
may well account for their biological actions (Li et 
al., 2013; Wu et al., 2013).  
Then, the aim of this study was to get insight 
about the mechanisms involved in the 
cardioprotective effects of different red wine 
varieties, Ilex paraguariensis, Ilex brasiliensis, 
Vaccinium meridionale Swartz, and  polyphenol-rich 
cocoa extracts, assessing the contribution of their ¨in 
vitro¨ antioxidant properties. A high polyphenols 
content with high antioxidant capacity are the 
common factors of the natural products extracts 
selected for this investigation.  
 
MATERIAL AND METHODS 
Cabernet-Sauvignon (CS), Malbec (M) and CS-M-
Merlot blend (BW) non-alcoholic red wine extracts,  
aqueous extracts  of  Ilex paraguariensis (Ip) and  
Ilex brasiliensis (Ib), fermented extract (FE) and 
berry juice (BJ) of Vaccinium meridionale Swartz 
and  polyphenol-rich cocoa extracts (A, B and C) 
were selected as natural products. 
 
Preparation of extracts 
Red wine 
Red wine (200 ml) was vacuum evaporated (< 30° C) 
to obtain 3-5 g of jelly-like extract. Then, this extract 
was solubilized in deionized double-distilled water 
and filtered. This resulting fluid was used in the 
experiments. CS, M and BW red wine were obtained 
from local supermarkets. The three red wines were 
from Mendoza (Argentina) and the year of 
production was 1998 or 1999. 
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Ip and Ib 
Aerial parts of Ilex brasiliensis (Sprengel) Loes and 
Ilex paraguariensis St. Hilarie, both species of 
Aquifoliaceae family, were collected from Cerro 
Azul (Misiones, Argentina) in April 2002. A vouche 
specimen of both samples were deposited in the 
herbarium of the Museo de Botánica y 
Farmacognosia ¨Carlos Spegazzini¨ (Universidad 
Nacional de La Plata, Argentina) under the numbers 
LPE 1005 and 938, respectively. The dried and 
powdered leaves of both Ilex species were extracted 
with hot water (90° C), left standing for 20 min, 
filtered and lyophilised. The dry matter was 
maintained at -20° C until it was used. Both extracts 
were dissolved in distilled water immediately before 
performing all tests (Schinella et al., 2009). 
 
Vaccinium meridionale Swartz 
The berry fruits were harvested at the beginning of 
December 2009 in Colombia, zone ¨El Retiro¨ (2175 
m.a.s.l.) into Antioquia region. The berry juice (BJ) 
was transferred into stainless steel tank and the 
fermentation was carried out at 25 ± 2° C for 10 days 
and stopped by the addition of SO2. This extract (FE) 
was decanted, treated with albumin, filtered and 
vacuum-evaporated. BJ was used as control. Both 
extracts were dissolved in distilled water immediately 
before performing all tests (Lopera et al., 2013). 
 
Polyphenol-rich cocoa extracts 
A, B and C fractions of fresh cocoa pods of the 
Amazonic-Trinitary variety (CCN51 clone) from the 
Quevedo region in Ecuador were obtained following 
the instructions detailed in our recent publication 
(Schinella et al., 2010).  
 
In vitro assays  
All determinations were performed by 
spectrophotometric methods using Beckman DU®640 
spectrophotometer.  
 
Determination of total phenol content 
Total phenol content of the extracts was determined 
using Folin Ciocalteu reagent (Singleton & Rossi, 
1965). Gallic acid was used as standard and the 
calibration curve was prepared in the range 2-20 
µg/mL (R2 =0.9983, p < 0.01), and the results were 
expressed as gallic acid equivalents/mg extract. 
 
Scavenging activities  
1-Diphenyl-2-picryl-hydrazyl (DPPH)  
Reduction of the stable free radical DPPH was 
determined with the aid of a modified version of the 
method described by Cavin et al. (1998).The results 
are expressed in 𝜇g caffeic acid equivalents/mg of 
dry weight of the extract. 
 
Superoxide (O2
-.) 
Superoxide -generated by enzymatic oxidation of 
hypoxanthine with xanthine oxidase- was determined 
following the nitroblue tetrazolium reduction at 560 
nm in presence of the extracts as was previously 
described by Schinella et al. (2009). 
 
Peroxynitrite Anion (ONOO-) 
ONOO- was synthesized in a quenched flow reactor 
in accordance with the method described by 
Koppenol et al. (1996). The pyrogallol red bleaching 
assay was carried out as reported by Balavoine and 
Geletii (1999). 
 
Isolated Heart Preparation 
All procedures followed during this investigation 
were approved by the Institutional Animal Care and 
Use Committee (IACUC) of the Faculty of Medicine, 
University of La Plata (P-05-2014) following the 
Guide for the Care and Use of Laboratory Animals 
published by the Nacional Research Council, 
National Academy Press, Washington DC 2010 
and/or European Union Directive for Animal 
Experiments 2010/63/UE. 
Male Wistar rats of 5-6 months of age were 
anesthetized with an intraperitoneal injection of 
sodium pentobarbital (60 mg/kg bodywt). The heart 
was excised and perfused through the aorta by the 
nonrecirculating Langendorff technique with 
Ringer’s solution (pH 7.4) and at 37º C. Heart rate 
was maintained at 280 ± 10 beats/min. A latex 
balloon was placed inside the left ventricle (LV) and 
connected to a Statham P23XL pressure transducer. 
The balloon was filled with water to provide an end-
diastolic pressure (LVEDP) of 8-12 mm Hg, and this 
volume was unchanged for the rest of the experiment. 
Coronary perfusion pressure was adjusted to 
approximately 60-70 mm Hg and coronary flow was 
11 ± 2 mL/min. Left ventricular pressure (LVP) was 
acquired by using an analog to-digital converter and 
acquisition software (Chart V4.2.3AD Instruments 
Sudamérica, Santiago de Chile, Chile). 
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Experimental Protocols 
After 10 min of stabilization, the following 
experimental protocols were performed: 
 
Ischemic control (IC) 
Hearts were subjected to 20 min of normothermic 
global ischemia followed by 30min of reperfusion. 
Global ischemia was induced by stopping the 
perfusate inflow line and the heart was placed in a 
saline bath held at 37° C.  
 
Treated hearts 
Hearts were treated 10 min before ischemia and the 
initial 10 min of reperfusion with 30 µg/ml of each 
one of the described extracts.   
Other groups of hearts received 1mM of NG-
nitro-L-arginine methyl ester (L-NAME), a 
nonselective nitric oxide synthase (NOS) inhibitor, 
20 min before ischemia and during the reperfusion 
period.  
 
Systolic and Diastolic Function  
Myocardial contractility was assessed through the left 
ventricular developed pressure (LVDP), obtained by 
subtracting LVEDP to the LVP peak values and the 
maximal rise velocity of the left ventricular pressure 
(+dP/dtmax). Data were expressed as percentages of 
their respective preischemic values. The diastolic 
function was evaluated through the isovolumic 
LVEDP. 
 
Oxidative damage of cardiac tissue 
At the end of reperfusion, hearts were frozen in liquid 
N2 and kept at −70º C until the moment of assays. 
 
Assessment of thiobarbituric acid reactive 
substances (TBARS) concentration 
A portion of LV was homogenized in a solution 
composed by 25 mM KH2PO4-140 mM KCl. Then 
the samples were centrifuged. In the supernatant 
TBARS -an index of lipid peroxidation- was 
determined. This assay is based on the reaction of 2-
thiobarbituric acid with malondialdehyde (MDA) to 
yield a chromophore with absorbance at 535nm 
(Buege & Aust, 1978). Data were expressed as nmol 
MDA/g tissue weight. 
 
Reduced Glutathione (GSH)  
Aliquots of homogenate were used to assess GSH 
according to Ellman’s method (Sedlak & Lindsay, 
1968) and expressed as µg GSH/g tissue weight. 
 
Western Blot Analysis 
Other portion of LV was homogenized in ice-cold 
RIPA buffer, centrifuged at 10000 × g for 15 min at 
4º C. The supernatant was collected and subjected to 
SDS-PAGE. The samples were transferred to a PVDF 
membrane (2 h). Equal loading of samples was 
confirmed by Ponceau S staining. Membranes were 
blocked with 5% nonfat milk in Tris-buffered saline 
(pH 7.5) containing 0.1% Tween (TBS-T) and probed 
overnight at 4∘C with antibodies anti-eNOS (Sigma-
Aldrich, St. Louis, MO, USA) and anti-Akt 
(Calbiochem, Merck Millipore Darmstadt, Germany). 
Membranes were washed four times for 10min in 
TBS-T prior to the addition of anti-rabbit secondary 
antibody (1 : 1000 dilution) and the antibody-antigen 
complexes were developed using a chemiluminescent 
system (ECL Plus; GE Healthcare, Buckinghamshire, 
UK). 
 
Statistical Analysis 
Data were expressed as means ± SE. Statistical 
analysis was performed by one-way analysis of 
variance (ANOVA) followed by Student-Newman-
Keuls multiple comparisons test. Differences were 
considered significant at P < 0.05. 
 
RESULTS  
The extracts herein considered possess different 
phenolic compounds. Thus, the non-alcoholic 
extracts of red wine (RWE) possess a high content of 
flavonoids (anthocyanins and tannins) and non-
flavonoids compounds, such as phenolic acids 
(Fanzone et al., 2010; Granato et al., 2011). The 
aqueous extracts of Ilex species (Ib and Ip) have 
phenylpropanoids and flavonols (Filip et al., 2001; 
Filip et al., 2008; Schinella et al., 2009), cocoa 
extracts (A, B and C) flavanol monomers and dimeric 
procyanidins (Schinella et al., 2010) and the extract 
obtained from Vaccinium meridionale Sw is enriched 
in anthocyanins (Garzón et al., 2010; Lopera et al., 
2013).  
Table 1 shows that the three red wine non-
alcoholic extracts (CS, M and BW) exerted a similar 
DPPH reduction and O2.- scavenging and non-
detectable ONOO- scavenging activity. These 
similarities were associated and/or attributed to a 
similar total phenols (TF) content found in the red 
wine extracts. Ib aqueous extract and B and C cocoa 
fractions showed the highest TF content whereas that 
Ib and C cocoa fraction showed the highest ONOO- 
scavenging activity. The berry juice (BJ) exhibited 
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the lowest values of all parameters, indicating the 
scarce antioxidant activity of that preparation. The B 
and C cocoa fractions also exhibited the highest 
values of O2.- scavenging activity. 
 
Table 1 
Total phenol content and ¨in vitro¨ assessment of antioxidant properties of the extracts 
TF: Total phenol content; Scavenging activity of DPPH (2,2-diphenyl-1-picrylhydrazyl radical), O2.- 
(superoxide) and ONOO- (peroxynitrite). RWE: samples of non-alcoholic red wine extract (CS: Cabernet-
Sauvignon, M: Malbec and BW: CS-M-Merlot blend; Ip: Ilex paraguariensis and Ib: Ilex brasiliensis 
aqueous extracts; FE and BJ: fermented extract and berry juice of Vaccinium meridionale Swartz; A, B and 
C: polyphenol-rich cocoa extracts. 
 
Sample TF (a) DPPH (a) O2.- (a) ONOO- (b) 
RWE     
CS   109.4 ± 17.2 27.0 ± 1.6 28,6 ± 2.0 ND 
M   103.4 ±   9.9 23.4 ± 2.1 22,6 ± 2.8 ND 
BW   115.5 ± 10.8 26.8 ± 1.9 26.7 ± 2.2 ND 
Ilex     
Ib 350.0 ± 27.8 159.8 ± 12.3 25.9 ± 2.1 58,3 ± 6.3 
Ip 230.0 ± 23.7 229.6 ± 19.1 31.1  ±2.8   8,3 ± 0.9 
VMS     
FE 59.5 ± 3.7 23.0 ± 1.5 5.6 ± 0.4 5.0 ± 0.2 
BJ 14.0 ± 0.8   5.0 ± 0.3 2.3 ± 0.3 1.3 ± 0.3 
Cocoa     
A 106.5 ± 9.1  63.5 ±  5.1   8.0 ± 0.6 14.9 ± 0.9 
B 759.3 ± 6.4 202.9 ± 16.8 68.4 ± 7.9 31.6 ± 2.7 
C 1007.6 ± 15.7 456.7 ± 22.2 74.7 ± 5.8 63.8 ± 5.1 
(a) Equivalent µg gallic acid/mg of extract 
(b) Equivalent µg ascorbic acid/mg of extract 
ND not determined 
 
 
Figure 1 shows typical traces of LVP in 
untreated (upper panel) and treated (lower panel) 
hearts during the three steps of the experiment 
(stabilization, global ischemia and reperfusion). 
Treated heart showed an improvement of 
postischemic myocardial function (characterized by 
an increase of LVDP and a decrease in LVEDP) after 
the treatment with an extract with protective action. 
LVDP and +dP/dtmax -expressed as percen-
tage of preischemic values- and LVEDP -expressed 
in mm Hg- at the end of reperfusion period in all 
experimental groups are depicted in Figure 2. Both 
parameters favourability changed when CS, M, Ip, Ib 
and FE extracts were administered compared to 
ischemic control hearts. Thus, in hearts treated with 
those extracts LVDP significantly increased reaching 
values of approximately 100 % in comparison to 
untreated ischemic hearts (58 ± 4%). The +dP/dtmax 
showed a similar pattern.  The increase of LVEDP 
detected in IC hearts was significantly attenuated by 
the treatments (6 to 19 for treated hearts vs. 44 
mmHg in IC). However, when BW or BJ extracts 
were infused it was unable to mitigate the myocardial 
postischemic alterations. Severe arrhythmias and 
abnormalities in myocardial function were registered 
in hearts treated with A, B and C cocoa fractions.  
An attenuation of cardiac oxidative stress 
submitted to ischemia-reperfusion was also detected 
after acute administration of the mentioned extracts. 
Thus, a decrease in TBARS concentration and a 
partial preservation of GSH was observed after CS, 
M, Ip, Ib and FE extracts administration (Figure 3). 
BW or BJ did not modify the values of those 
parameters observed in IC hearts. 
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Figure 1 
Typical traces of left ventricular pressure (LVP) during ischemia and reperfusion in untreated (upper panel) 
and treated hearts (lower panel). Note that the sample produced an increase of left ventricular developed 
pressure (LVDP) and a decrease of left ventricular end diastolic pressure (LVEDP). 
 
 
 
Figure 2 
Values of left ventricular developed pressure (LVDP) and +dP/dtmax -expressed as percentage of preischemic 
values- and left ventricular end diastolic pressure (LVEDP)- expressed in mmHg-  at the end of reperfusion, 
in ischemic control hearts (IC) and hearts treated with extracts of CS, M, BW, Ip, Ib, FE and BJ.  
* p < 0.05 vs IC 
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Figure 3 
Thiobarbituric acid reactive substances (TBARS) concentration and reduced glutathione content (GSH) in 
IC and in hearts treated with CS, M, BW, Ip, Ib, FE and BJ. *p < 0,05 vs IC 
 
 
Figure 4 
Relationship between left ventricular developed pressure (LVDP) and TBARS (upper panel) and GSH 
(lower panel) in all experimental situations. Data were fitted to straight line by linear regression and 
significant correlations were found. 
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Figure 4 shows the relationships between 
TBARS or GSH and LVDP. The analysis of data 
demonstrated the existence of a negative correlation 
between postischemic recovery of systolic function, 
assessed by LVDP and TBARS (an index of lipid 
peroxidation). Also, a positive correlation was found 
between GSH content and LVDP indicating that 
higher levels of GSH are associated to an 
improvement of recovery of myocardial function 
(lower panel).  
A diminution of P-Akt and eNOS 
concentration was detected in IC hearts and this level 
increased after the treatment with CS, M, Ip, Ib and 
FE extracts (Figure 5) and were not modified when 
BW and BJ were added.  
The blockade of NOS with L-NAME 
abolished the improvement of postischemic recovery 
of systolic function and the attenuation of diastolic 
stiffness afforded by the extracts. In this condition, a 
decrease of eNOS and P-Akt content was also evident 
(data not shown). 
 
 
 
Figure 5 
Representative immunoblots and summary of densitometry data of eNOS (A panel), and phospho-Akt (P-
Akt, B panel) in cardiac homogenate of ischemic control (IC) and hearts treated with CS, M, BW, Ip, Ib , FE 
and BJ extracts. * p< 0.05 vs. IC. 
 
DISCUSSION 
Our data show that non-alcoholic extracts of CS and 
M red wine, aqueous extracts of two Ilex species (Ip 
and Ib) and Vaccinium meridionale Sw fermented 
extract attenuate the myocardial contractile 
dysfunction and oxidative damage produced by 
ischemia and reperfusion. However, the BW, BJ and 
polyphenols-riched fractions of cocoa are not 
beneficial in the same conditions.  
It is recognized that Ca2+ overload linked to a 
large burst of ROS which takes place early during 
reperfusion are responsible of the transitory 
postischemic dysfunction (Takano et al., 2003; 
Yellon & Hausenloy, 2007) having to the 
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mitochondrial permeability transition pore (mPTP) as 
the end target (Wong et al., 2012). Therefore, any 
treatment able to reduce the intracellular Ca2+ 
concentration or ROS would be beneficial. All the 
extracts used in this study exhibited a significant ¨in 
vitro¨ antioxidant capacity. Then, the improvement of 
postischemic myocardial function observed after the 
acute treatment with the extracts could be ¨a priori¨ 
attributed to their antioxidant properties. This 
conclusion is invalid because the cocoa fractions 
which possesses the highest phenols content and O2.- 
and ONOO- scavenging activity were not effective to 
attenuate the myocardial dysfunction. These data 
constitute a first and strong evidence of a lack of 
relationship between both actions. Thus, a high ¨in 
vitro¨ antioxidant capacity of an extract is not a ¨sine 
qua non¨ condition to protect the heart against 
reperfusion injury.  
Our data also show that the improvement of 
myocardial dysfunction was accompanied by an 
attenuation of oxidative stress evidenced by a 
diminution of TBARS (as index of lipid 
peroxidation) and a significant increase of GSH 
content. These results suggest that a low ROS 
production or release could be occurring when those 
protective extracts are administered to the hearts 
before and after ischemia.  
It is known that NO is released during 
ischemia and at the beginning of reperfusion by 
activation of NOS, particularly the endothelial 
isoform (Schulz et al., 2004). Also, the ROS-
mediated oxidation of eNOS essential cofactor 
tetrahydrobiopterin (BH4) turns to the enzyme in a 
system of O2.-  production (Dumitrescu et al., 2007). 
The interaction of O2.- with NO produces ONOO- 
which causes nitration of tyrosine residues.  Thus, 
both process -protein nitration and lipid peroxidation- 
are contributing to the postischemic oxidative 
damage (Valko et al., 2007). In this sense, it was 
previously described that the balance between NO 
and ROS generation, the so-called ‘‘nitroso/redox 
balance’’ plays a crucial role in the modulation of 
ischemic alterations (Heusch et al., 2008; Nediani et 
al., 2011). In this study, the western blot analysis 
showed an increased eNOS expression in hearts 
treated with protective extracts but was not observed 
with non-protective extracts (BW and BJ).  
Current evidence suggest that the protective 
effect occurs activating pro-survival signalling 
cascade which involve among others the 
phosphatidylinositol 3-kinase/Akt (PI3K/Akt), the 
extracellular signal-regulated kinase (ERK1/2) and 
adenosine monophosphate-activated kinase (AMPK) 
(Rusell et al., 2004; Hausenloy & Yellon, 2007). 
Recently, Akt and ERK1/2 appeared involved in the 
green tea-mediated beneficial effects (Kim et al., 
2014). On the other hand, it has been previously 
reported the ability of plant-derived agents to activate 
AMPK (Srivastava et al., 2012) and the AMPK-
mediated eNOS phosphorylation and activation 
(Young, 2008). In our experimental conditions, an 
activation of Akt in treated hearts with the protective 
extracts was also observed. This change occurred 
simultaneously with those of eNOS indicating that 
Akt-eNOS pathway could be involved in the 
cardioprotection. 
Which are the targets of NO? Previous 
reports show that the beneficial actions of NO are 
mediated by an attenuation of mPTP opening GMPC -
dependent or independent and probably through the 
mitochondrial ATP-dependent K channels 
(mitoKATP) opening (Sasaki et al., 2000; Schulz et 
al., 2004). The participation of these channels in the 
cardioprotection exerted by a non-alcoholic extract of 
CS red wine was previously demonstrated by us 
(Mosca & Cingolani, 2002). These actions could 
explain a lesser mitochondrial ROS release and/or 
production and the consequent lesser oxidative 
damage observed after the effective treatments.  
All data obtained in this study indicate that 
the protective effects of the extracts on the alterations 
derived from ischemia and reperfusion are mediated 
by NO-dependent cascades. 
Which compounds would be responsible of 
the cardioprotection? Although the ¨in vitro¨ 
experiments performed in this study are crucial to 
screen the effects, security, efficiency, and other 
biochemical parameters, the extract-derived bioactive 
molecules cannot be identified. Furthermore, these 
compounds possess several modes of action, 
establishing synergic, antagonist, and polyvalent 
relationships with other compounds, besides suffering 
chemical changes due to organic metabolism.  In our 
experimental conditions we can only ensure that the 
principal components of the polyphenol-rich cocoa 
extracts (procyanidinB2, epicatechin) are not 
participate in the cardioprotection. 
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CONCLUSION 
The present study demonstrates that although the 
extracts have significant antioxidant capacities not all 
are beneficial against ischemia-reperfusion injury. 
This fact is the first indication that ¨in vitro¨ 
antioxidant capacity does not keep strict correlation 
with the protective effect on postischemic myocardial 
function. Therefore, we propose that some 
components present in the extracts of natural 
products by interaction with membrane receptors are 
able to activate eNOS via PI3K/Akt. The consequent 
increase of NO production could exert its beneficial 
actions limiting the mPTP opening (Figure 6).
  
 
 
Figure 6 
Proposed mechanism for the NO-dependent cardioprotection against ischemia-reperfusion injury afforded 
by the extract of natural products 
 
Finally, the discrepancies in the outcome of 
intervention studies may be understood if, instead of 
considering the simple paradigm of bad oxidants and 
good antioxidants, scientists will start to talk about 
the real molecular function of such compounds in 
each particular situation. Hence, although 
contradictory results were obtained in the trials about 
the effects of antioxidant supplementation, the 
recommendation of a healthy diet, rich in fruits and 
vegetables and whole brain foods, is still standing. 
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